Hepatitis C: Grading and Staging by MR
This study has been completed.
Sponsor:
Information provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:
NCT00059397
First received: April 24, 2003
Last updated: March 17, 2010
Last verified: March 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To compare MR imaging findings with biopsy for grading and staging early hepatitis C.
| Condition |
|---|
|
Hepatitis |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Hepatitis C: Grading and Staging by MR |
Resource links provided by NLM:
Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
Eligibility| Ages Eligible for Study: | 18 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Referral only
Contacts and Locations More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00059397 History of Changes |
| Other Study ID Numbers: | R03 (DK62765) (completed 2007) |
| Study First Received: | April 24, 2003 |
| Last Updated: | March 17, 2010 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
|
Hepatitis C |
Additional relevant MeSH terms:
|
Hepatitis Hepatitis A Hepatitis C Liver Diseases Digestive System Diseases Hepatitis, Viral, Human |
Virus Diseases Enterovirus Infections Picornaviridae Infections RNA Virus Infections Flaviviridae Infections |
ClinicalTrials.gov processed this record on June 17, 2013